BNT162b2信使核糖核酸新冠疫苗在全国大规模疫苗接种中的应用。回复 - Suppr

Suppr

超能文献

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.

作者信息

Barda Noam, Dagan Noa, Balicer Ran D

机构信息

Clalit Research Institute, Tel Aviv, Israel

出版信息

N Engl J Med. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

DOI:10.1056/NEJMc2104281

PMID:33882227

Abstract

摘要

相似文献

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.

N Engl J Med. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

N Engl J Med. 2021 May 20;384(20):1968-1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.

N Engl J Med. 2021 Apr 22;384(16):1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.

Int J Infect Dis. 2021 Jul;108:116-118. doi: 10.1016/j.ijid.2021.05.021. Epub 2021 May 13.

Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England.

BMC Med. 2021 Oct 18;19(1):275. doi: 10.1186/s12916-021-02149-4.

Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.

Kidney Int. 2021 Jun;99(6):1494-1496. doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.

Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.

Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.

J Infect. 2021 Aug;83(2):e4-e5. doi: 10.1016/j.jinf.2021.06.024. Epub 2021 Jun 30.

引用本文的文献

SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression.

Virol J. 2024 Mar 27;21(1):75. doi: 10.1186/s12985-024-02342-w.

Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.

Theranostics. 2024 Jan 1;14(2):738-760. doi: 10.7150/thno.84291. eCollection 2024.

Bibliometric analysis of the highly cited publications in COVID-19 vaccine.

Heliyon. 2023 Jul 23;9(8):e18540. doi: 10.1016/j.heliyon.2023.e18540. eCollection 2023 Aug.

Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.

PLoS One. 2022 Dec 6;17(12):e0278624. doi: 10.1371/journal.pone.0278624. eCollection 2022.

The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.

Isr J Health Policy Res. 2022 Nov 23;11(1):39. doi: 10.1186/s13584-022-00548-3.

Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.

PLoS One. 2022 Nov 18;17(11):e0274526. doi: 10.1371/journal.pone.0274526. eCollection 2022.

Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan.

Front Public Health. 2022 Sep 21;10:1008521. doi: 10.3389/fpubh.2022.1008521. eCollection 2022.

Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.

Eur J Haematol. 2023 Jan;110(1):99-108. doi: 10.1111/ejh.13878. Epub 2022 Oct 23.

Efficacy of COVID-19 vaccines.

Microb Pathog. 2022 Oct;171:105729. doi: 10.1016/j.micpath.2022.105729. Epub 2022 Sep 2.

Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection.

Ir J Med Sci. 2023 Apr;192(2):731-739. doi: 10.1007/s11845-022-03044-4. Epub 2022 Jun 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.

作者信息

Barda Noam, Dagan Noa, Balicer Ran D

机构信息

Clalit Research Institute, Tel Aviv, Israel

出版信息

N Engl J Med. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

DOI:10.1056/NEJMc2104281

PMID:33882227

Abstract

摘要

相似文献

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.

N Engl J Med. 2021 May 20;384(20):1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

N Engl J Med. 2021 May 20;384(20):1968-1970. doi: 10.1056/NEJMc2104281. Epub 2021 Apr 21.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. Reply.

N Engl J Med. 2021 Apr 22;384(16):1578. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.

Int J Infect Dis. 2021 Jul;108:116-118. doi: 10.1016/j.ijid.2021.05.021. Epub 2021 May 13.

Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England.

BMC Med. 2021 Oct 18;19(1):275. doi: 10.1186/s12916-021-02149-4.

Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won.

Kidney Int. 2021 Jun;99(6):1494-1496. doi: 10.1016/j.kint.2021.04.010. Epub 2021 Apr 20.

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.

Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

N Engl J Med. 2021 Apr 22;384(16):1576-1577. doi: 10.1056/NEJMc2036242. Epub 2021 Feb 17.

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.

Ann Intern Med. 2021 Feb;174(2):JC15. doi: 10.7326/ACPJ202102160-015. Epub 2021 Feb 2.

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers.

J Infect. 2021 Aug;83(2):e4-e5. doi: 10.1016/j.jinf.2021.06.024. Epub 2021 Jun 30.

引用本文的文献

SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression.

Virol J. 2024 Mar 27;21(1):75. doi: 10.1186/s12985-024-02342-w.

Nanoparticle technology for mRNA: Delivery strategy, clinical application and developmental landscape.

Theranostics. 2024 Jan 1;14(2):738-760. doi: 10.7150/thno.84291. eCollection 2024.

Bibliometric analysis of the highly cited publications in COVID-19 vaccine.

Heliyon. 2023 Jul 23;9(8):e18540. doi: 10.1016/j.heliyon.2023.e18540. eCollection 2023 Aug.

Effectiveness of Pfizer-BioNTech COVID-19 vaccine as evidence for policy action: A rapid systematic review and meta-analysis of non-randomized studies.

PLoS One. 2022 Dec 6;17(12):e0278624. doi: 10.1371/journal.pone.0278624. eCollection 2022.

The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines.

Isr J Health Policy Res. 2022 Nov 23;11(1):39. doi: 10.1186/s13584-022-00548-3.

Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.

PLoS One. 2022 Nov 18;17(11):e0274526. doi: 10.1371/journal.pone.0274526. eCollection 2022.

Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan.

Front Public Health. 2022 Sep 21;10:1008521. doi: 10.3389/fpubh.2022.1008521. eCollection 2022.

Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.

Eur J Haematol. 2023 Jan;110(1):99-108. doi: 10.1111/ejh.13878. Epub 2022 Oct 23.

Efficacy of COVID-19 vaccines.

Microb Pathog. 2022 Oct;171:105729. doi: 10.1016/j.micpath.2022.105729. Epub 2022 Sep 2.

Immune response to COVID-19 vaccination in a population with and without a previous SARS-CoV-2 infection.

Ir J Med Sci. 2023 Apr;192(2):731-739. doi: 10.1007/s11845-022-03044-4. Epub 2022 Jun 9.